SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001847903-22-000095
Filing Date
2022-11-23
Accepted
2022-11-23 17:00:01
Documents
1
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 4/A wf-form4a_166924078321809.html 4/A  
1 FORM 4/A wf-form4a_166924078321809.xml 4/A 2868
  Complete submission text file 0001847903-22-000095.txt   4432
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Issuer) CIK: 0001847903 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CENTESSA PHARMACEUTICALS PLC D. HODGKIN BLDG, BABRAHAM RSRCH CAMPUS CAMBRIDGE X0 CB22 3FH
Business Address
HUSSAIN IQBAL J (Reporting) CIK: 0001862050 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-40445 | Film No.: 221416939